ARVN
Arvinas Inc
Price:  
9.54 
USD
Volume:  
2,224,869.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Arvinas EV/EBITDA

-300.0%
Upside

As of 2025-11-05, the EV/EBITDA ratio of Arvinas Inc (ARVN) is -5.10. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Arvinas's latest enterprise value is 586.03 mil USD. Arvinas's TTM EBITDA according to its financial statements is -114.80 mil USD. Dividing these 2 quantities gives us the above Arvinas EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.7x - 15.0x 11.4x
Forward P/E multiples 12.5x - 15.4x 15.0x
Fair Price (17.92) - (21.96) (19.08)
Upside -287.9% - -330.2% -300.0%
9.54 USD
Stock Price
(19.08) USD
Fair Price

Arvinas EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-11-03 -5.22
2025-10-31 -5.49
2025-10-30 -5.35
2025-10-29 -5.14
2025-10-28 -5.08
2025-10-27 -5.18
2025-10-24 -4.89
2025-10-23 -4.86
2025-10-22 -4.96
2025-10-21 -5.18
2025-10-20 -5.22
2025-10-17 -5.09
2025-10-16 -5.19
2025-10-15 -5.05
2025-10-14 -5.02
2025-10-13 -5.27
2025-10-10 -5.05
2025-10-09 -5.14
2025-10-08 -5.24
2025-10-07 -4.95
2025-10-06 -5.16
2025-10-03 -5.15
2025-10-02 -4.93
2025-10-01 -4.84
2025-09-30 -4.45
2025-09-29 -4.46
2025-09-26 -4.29
2025-09-25 -3.96
2025-09-24 -3.95
2025-09-23 -3.82
2025-09-22 -3.82
2025-09-19 -3.81
2025-09-18 -3.94
2025-09-17 -3.87
2025-09-16 -3.89
2025-09-15 -3.95
2025-09-12 -3.95
2025-09-11 -4.00
2025-09-10 -4.01
2025-09-09 -4.12
2025-09-08 -4.08
2025-09-05 -4.01
2025-09-04 -3.87
2025-09-03 -4.06
2025-09-02 -4.06
2025-08-29 -3.95
2025-08-28 -3.97
2025-08-27 -4.17
2025-08-26 -3.83
2025-08-25 -3.79